<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>pharmalicensing.com: Industry news</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>pharmalicensing.com: Industry news</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.jpg</url>
			<width>144</width>
		</image>
								<item>
				<title>From Oranienburg to the rest of the world: global market launch of Daxas</title>
				<description>September 01, 2010 -- Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/531026/0/15/from-oranienburg-to-the-rest-of-the-world-global-market-launch-of-daxas</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/531026/0/15/from-oranienburg-to-the-rest-of-the-world-global-market-launch-of-daxas</guid>
			</item>
					<item>
				<title>Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report</title>
				<description>CHICAGO, Aug 24, 2010 - Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/530735/0/15/advanced-life-sciences-sees-funding-opportunity-for-restanza-in-new-hhs-medical-countermeasure-report</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/530735/0/15/advanced-life-sciences-sees-funding-opportunity-for-restanza-in-new-hhs-medical-countermeasure-report</guid>
			</item>
					<atom:link href="http://pharmalicensing.com/public/public/news/latest/0/15.rss" rel="self" type="application/rss+xml" />
	</channel>
</rss>
